{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:01:29Z","timestamp":1790402489840,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04275-5","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:23:12Z","timestamp":1790400192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of serum myelin basic protein in POAG patients at a tertiary institution in Lagos, Nigeria"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3910-8359","authenticated-orcid":false,"given":"Judith Ogechi","family":"Anikwenwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-6967","authenticated-orcid":false,"given":"Adetunji Olusesan","family":"Adenekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adegboyega Sunday","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatobi Olalekan","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-7869","authenticated-orcid":false,"given":"Ademola Ayoda","family":"Sule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufisayo Temitayo","family":"Aribaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Oladapo","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeola Olukorede","family":"Onakoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"4275_CR1","first-page":"41","volume":"2","author":"LM Shahsuvaryan","year":"2013","unstructured":"Shahsuvaryan LM (2013) Glaucomatous optic neuropathy management: the role of neuroprotective agents. Med hypothesis, Discov Innov Ophthalmol 2:41\u201346","journal-title":"Med hypothesis, Discov Innov Ophthalmol"},{"key":"4275_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874364100903020059","volume":"3","author":"R Susanna Jr","year":"2009","unstructured":"Susanna R Jr, Vessani RM (2009) Staging glaucoma patient: why and how? Open Ophthalmol J 3:59\u201364","journal-title":"Open Ophthalmol J"},{"key":"4275_CR3","first-page":"19","volume":"1","author":"GL Spaeth","year":"2005","unstructured":"Spaeth GL (2005) The disc damage likelihood scale. Glaucoma Today 1:19\u201321","journal-title":"Glaucoma Today"},{"key":"4275_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awy338","volume":"142","author":"Y You","year":"2019","unstructured":"You Y, Joseph C, Wang C et al (2019) Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease. Brain 142:426\u2013442","journal-title":"Brain"},{"key":"4275_CR5","first-page":"378","volume-title":"Seminars in ultrasound, CT and MRI","author":"TA Freddi","year":"2022","unstructured":"Freddi TA, Ottaiano AC (2022) The optic nerve: anatomy and pathology. In: Gayer G (ed) Seminars in ultrasound, CT and MRI, 1st ed. Elsiever, Philadelphia, pp 378\u2013388","edition":"1st ed"},{"key":"4275_CR6","first-page":"180","volume-title":"Ocular disease mechanisms and management","author":"CT James","year":"2010","unstructured":"James CT (2010) Ocular disease mechanisms and management, 1st ed. Elsevier, Philadelphia, pp 180\u2013183","edition":"1st ed"},{"key":"4275_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a017269","volume":"4","author":"I Soto","year":"2014","unstructured":"Soto I, Howell GR (2014) The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med 4:1\u201316","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4275_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00701-019-04185-9","volume":"162","author":"N W\u0105sik","year":"2020","unstructured":"W\u0105sik N, Sok\u00f3\u0142 B, Ho\u0142ysz M et al (2020) Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir 162:545\u2013552","journal-title":"Acta Neurochir"},{"key":"4275_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/B978-0-12-812344-7.00016-9","volume-title":"Neurosensory disorders in mild traumatic brain injury","author":"R Smith","year":"2019","unstructured":"Smith R, Chepisheva M, Cronin T et al (2019) Diagnostic approaches techniques in concussion\/mild traumatic brain injury: where are we? In: Michael E (ed) Neurosensory disorders in mild traumatic brain injury, 1st ed. Academic press, Florida, pp 247\u2013277","edition":"1st ed"},{"key":"4275_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2990.2012.01279.x","volume":"39","author":"TG D\u2019Aversa","year":"2013","unstructured":"D\u2019Aversa TG, Eugenin EA, Lopez L et al (2013) Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain-barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol 39:270","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4275_CR11","unstructured":"Torre A (2023) Catalyst for a cure. Glaucoma Research Foundation. 1:1\u201315"},{"key":"4275_CR12","first-page":"1","volume":"11","author":"YJ Shin","year":"2021","unstructured":"Shin YJ, Kim E, Han BK et al (2021) Serum biomarkers for the diagnosis of glaucoma. Diagnostics 11:1\u201314","journal-title":"Diagnostics"},{"key":"4275_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10792-014-9903-2","volume":"34","author":"BJ Adekoya","year":"2014","unstructured":"Adekoya BJ, Shah SP, Onakoya AO et al (2014) Glaucoma in southwest Nigeria: clinical presentation, family history and perceptions. Int Ophthalmol 34:1027\u20131036","journal-title":"Int Ophthalmol"},{"key":"4275_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/0189-9171.142747","volume":"22","author":"O Olawoye","year":"2014","unstructured":"Olawoye O, Tarella S (2014) Spectrum of glaucoma presentation in a Nigerian tertiary hospital. Niger J Ophthalmol 22:11\u201315","journal-title":"Niger J Ophthalmol"},{"key":"4275_CR15","doi-asserted-by":"crossref","unstructured":"Olawoye O, Kizor-Akaraiwe N, Pons J, et al. STAGE Research Group (2022) Clinical characteristics and stage at presentation of glaucoma patients in Sub-Saharan Africa. J Glaucoma 31(9):717-723","DOI":"10.1097\/IJG.0000000000002068"},{"key":"4275_CR16","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"4275_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/OR\/2016\/31121","volume":"6","author":"S Adegbehingbe","year":"2016","unstructured":"Adegbehingbe S, Olusanya B, Ajayi B et al (2016) Central cornea thickness in glaucoma and non-glaucoma African population. Ophthalmol Res Int J 6:1\u20138","journal-title":"Ophthalmol Res Int J"},{"key":"4275_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/IJG.0b013e31829d9bb0","volume":"24","author":"B Siesky","year":"2015","unstructured":"Siesky B, Harris A, Racette L et al (2015) Differences in ocular blood flow in glaucoma between patients of African and European descent. J Glaucoma 24:117\u2013121","journal-title":"J Glaucoma"},{"key":"4275_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/ICU.0000000000000245","volume":"27","author":"P Louis","year":"2016","unstructured":"Louis P (2016) Vascular and autonomic dysregulation in primary open-angle Glaucoma. Curr Opin Ophthalmol 27:94\u2013101","journal-title":"Curr Opin Ophthalmol"},{"key":"4275_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-015-0160-6","volume":"15","author":"F Kyari","year":"2015","unstructured":"Kyari F, Entekume G, Rabiu M et al (2015) A population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria national blindness and visual impairment survey. BMC Ophthalmol 15:1\u201315","journal-title":"BMC Ophthalmol"},{"key":"4275_CR21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1212\/WNL.0b013e3182918cc2","volume":"80","author":"A Langer-Gould","year":"2013","unstructured":"Langer-Gould A, Brara SM, Beaber BE et al (2013) Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 80:1734\u20131739","journal-title":"Neurology"},{"key":"4275_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8718736","volume":"2020","author":"C Rodney","year":"2020","unstructured":"Rodney C, Rodney S, Millis RM (2020) Vitamin D and demyelinating diseases: neuromyelitis optica (NMO) and multiple sclerosis (MS). Autoimmune Dis 2020:1\u20139","journal-title":"Autoimmune Dis"},{"issue":"9","key":"4275_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13091423","volume":"13","author":"LA Levchuk","year":"2023","unstructured":"Levchuk LA, Roschina OV, Mikhalitskaya EV et al (2023) Serum levels of S100B protein and myelin basic protein as a potential biomarkers of recurrent depressive disorders. J Pers Med 13(9):1423","journal-title":"J Pers Med"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04275-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04275-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04275-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:23:14Z","timestamp":1790400194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04275-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04275-5","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they do not have any conflict of interest. The authors had no financial obligation to any of the products or equipment used in this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval (ADM\/DSCST\/HREC\/APP\/5705) was obtained from the Health Research Ethics Committee of the Lagos University Teaching Hospital, LUTH, Lagos, Nigeria. The study adhered strictly to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants after a detailed explanation of the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper is part of a dissertation submitted to the National Postgraduate Medical College of Nigeria in partial fulfillment of the requirements for the award of Fellowship of the Medical College (Ophthalmology), November 2024. It was delivered as a poster presentation at the Association of Nigerian Physicians in America (ANPA) Conference, April 10th, 2025, in Lagos, Nigeria.","order":4,"name":"Ethics","label":"Previous presentation","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"407"}}